emphasizes the reality of slow progress made in the last 30 years in both early diagnosis and treatment despite the amount of research effort, improved techniques of management, reduction of hospital morbidity and more effective rehabilitation. As a result, specialists and general practitioners are required to offer some form of palliative treatment to the majority (i.e. 60-70%) of patients. It should also be said that there is often no clear-cut distinction between what may comprise 'palliative' or 'curative' treatment in a considerable range of advanced (T3 or T4, N-+) tumours. In some cases, even palliation may be so effective that curative treatment may become feasible. Local control of the disease must always be the principal objective of any treatment whether the aim is palliative or curative.
Place of conventional treatment methods Surgery
The technical advances in ablative and reconstructive surgery with reduction of morbidity and functional restoration during the past 20 years have considerably increased the scope for major palliative surgery. This applies particularly to patients incurable by virtue of small inoperable metastases in lungs, mediastinum or elsewhere with minimal symptoms, and in whom loco-regional disease is causing severe pain and deteriorating function.
Some patients otherwise in reasonable health and presenting with extensive T3 or T4 squamous cancers of oral or pharyngeal sites, and with or without early distant metastases or with second primary cancer, may now be treatable palliatively by radical resection and immediate repair using regional pedicle or free flap techniques. Total glossectomy with myocutaneous flap repair for diffuse tongue infiltration with no obvious metastases after unsuccessful irradiation is a good example of this blurred area between surgical palliation and cure.
Other examples of major resection and repair for palliation are pharyngo-laryngo-oesophagectomy and total thyroidectomy, with gastric or colon replacement in the presence of covert or overt 0141-0768/86/ non-resectable metastatic disease. The use of rad-020084-03/$02.00 ical neck dissection for cervical metastasis from 19i an unknown primary site is a classic example of The Royal surgical palliation and occasional cure.
Society of
Despite such illustrations of the modern role of Medicine radical surgery in palliation, the value of minor surgical procedures remains a keystone of such treatment and in recent years their scope has been considerably extended, notably by the advent of lasers and the cryoprobe2.
Maintaining the patency of the air and food passages is an imperative functional aim. The use of an 'ostomy' procedure for relief of symptoms and to enable patients to be nursed at or near home whilst remaining ambulant will be valuable, but to be effective these operations should be undertaken early in the course of a terminal illness. Herein lies a moral dilemma, for late intervention in a depleted bedridden patient will be no service to him. The same may also be said for any surgical intervention where the benefit may be of only short duration or where surgery or general anaesthesia will probably add to a patient's debility. In planning such procedures the patient's morale and attitude to his condition must always be taken into account.
If oral or pharyngeal tumours become untreatable, the problems of nutrition are often best overcome using a cervical oesophagostomy rather than nasogastric or gastrostomy tubes. In oesophageal cancer, feeding tubes and gastrostomies do not relieve the dysphagia, the pain or the anorexia. In 1980 Belsey3 stated: 'Compassion demands that the surgeon attempts to relieve the dysphagia by one of the standard palliative operations. If the patient dies nothing is lost but the surgeon's vanity.' But again the-patient's own attitude and general condition must be taken into account when making a decision. The options, therefore, are palliative resection and reconstruction, or various bypass operations or intubationin that orderbearing in mind that relief of dysphagia by any form of oesophageal intubation is often uncertain and of short duration.
For gross recurrence of oral or sinus cancer, modern techniques of cryosurgery or CO2 laser application may be used with local or even no anaesthesia to debulk obstructing tumour, control haemorrhage or relieve pain and can be repeated if necessary. The argon tunable dye laser used with cell-sensitizing haematoporphyrin derivative offers palliative help in controlling inoperable and superficial recurrences in the head and neck by phototherapy.
For control of intractable pain, anaesthetists and neurologists can offer effective absolute alcohol blocks of sensory cranial nerves and specific nerves of the cervical plexus, preceded usually by trial injections or local anaesthesia. ENT surgeons and neurosurgeons can -also contribute to this type of palliation by peripheral neurolysis, central tractotomy and leukotomy as a last resort4-Surgery, therefore, has a large and important role to play in palliation, as well as still being the principal method available for curative treatment of H J Shaw MA FRCS Head and Neck Unit, Royal Marsden Hospital, London SW3 Journal of the Royal Society ofMedicine Volume 79 February 1986 86 head and neck cancer. But above all, surgeons must nevertheless decide when not to operate.
Radiotherapy
The principal options of teleradiation therapy, curietherapy using radioactive implants or applicators, and radioisotope therapy may all be used on occasions with advantage. Problems in the application of the first two techniques frequently involve retreatment of tissues previously irradiated. Using teletherapy, -careful planning of ports of entry is necessary to avoid overlap of fields, or it may occasionally be given through non-irradiated skin flaps replacing previously irradiated skin. The use of smaller dosage fractions over a longer period and the use of 'grid' filtration may make possible the retreatment of local disease and of fixed masses in the neck. Unfortunately, many other factors will enter into a plan for external palliative irradiation which can also influence the result. For squamous cancer palliative doses need to be high: 60-65 Gy over 6-7 weeks, although 50 Gy in 4 weeks may be successful.
Unresectable neck metastases in previously irradiated areas are probably best palliated by an intraoperative technique using a permanent implant of radioactive gold grains or a temporary wire implant of radioactive iridium 192 inserted by the after-loading technique. It is prudent in such cases to remove all damaged irradiated skin at the time of placing the implant, and to repair the defect with a non-irradiated, well vascularized myocutaneous flap for cover.
The palliation of distant metastases in skin, soft tissues or bone can be carried out with more rapid dose schedules such as 30 Gy in 10 fractions over 2 weeks with good responses.
The use of oral radioisotopes such as 131I is confined to treating inoperable metastases of differentiated thyroid gland cancer shown to have good uptake. In such cases excellent palliation can be obtained by therapy doses and sometimes an unexpected cure, the picture being much influenced by the unique behaviour of these tumours.
Cytotoxic chemotherapy
Without exceptionally strong evidence of a likely response, no cytotoxic agent with toxic side effects should be used for palliation. As a rule, responses of squamous cancer to most drug protocols are poor in a locally recurrent tumour situation where the tissues have already received previous treatment. At the Royal Marsden Hospital it is considered that the place of cytotoxic chemotherapy is by initial intravenous addition before conventional therapy for cure of squamous cancer in the previously untreated patient, and not as the last resort in a previously treated and palliative situation where partial response rates are likely to be no more than 40%.
If a palliative cytotoxic effort is to be made for a patient with extensive recurrent disease, usually an individual in poor general health, careful use of a minimally toxic protocol such as Price-Hill A or sequential VBM (vinblastine, bleomycin, methotrexate) with teleradiation may give a satisfactory response and sometimes make subsequent resection for cure a possibility7. The less toxic secondgeneration cisplatinum analogues such as JM 8 or JM 10 used sequentially with radiation also have recently been found effective and appear better tolerated than the original cisplatinum.
Drugs
For relief ofpain, reduction of anxiety or depression, and the promotion of rest and well-being at any stage of a terminal illness from any cancer, the use of drugs acting upon the nervous system, whether peripheral or central, remains mandatory and the first duty of doctors or nurses caring for the patient. Today, the range and effectiveness of available analgesic, hypnotic, and psychotropic drugs makes it possible to alleviate such symptoms and obtain constant relief for patients both in hospital or at home8. Administration of drugs, when needed, should always be planned on a regular and continued basis to prevent the onset of symptoms. The type of drug, its dosage and frequency should be selected to suit the individual on a rising strength of potency when symptoms are progressivebearing in mind that not all pain is due to cancer and that other drugs or treatment may be needed, and also remembering the need to use drugs for the relief of other common associated symptoms such as nausea and vomiting, mucosal dryness and discomfort, constipation, haemorrhage, etc9.
The range of drugs available today is so wide that it is convenient and practical to become familiar with the actions of a small series of about 8 or 10 main products, rather than choosing at random among unfamiliar medications in the hope of finding a suitable drug for a given situation. Most patients initially willderive some 'affective' pain relief from the interest and regular sympathetic attention of their trusted doctor. Simple medication, using non-narcotic analgesics and a suitable psychotropic drug with a mild hypnotic at night, will often then control the 'nociceptive' pain component until narcotics are required. Acupuncture techniques may also prove useful as adjuncts to pain control at this stage.
Strong narcotic analgesics remain the mainstay of treatment for pain, but the administration of drugs such as pethidine, morphine, diamorphine and their analogues should be delayed as long as possible. Heroin has the advantage of being more soluble in water so that high doses can be given in a small liquid volume. When started, they must then be given in effective regular doses, preferably as elixirs or by injection, and may usefully be combined with a low-dose steroid such as dexamethasone or with chlorpromazine. The newer, slow-release morphine sulphate tablet (MST) enables an adequate dose to be given only twice daily. General palliative measures Where? When? By whom? Since the family will be the focus of treatment, the decision as to where the patient should live and be nursed must be discussed with them by the doctor primarily in charge of the case. Generally it will be desirable for the patient to be treated at home whenever possible, have access to expert domiciliary nursing and depend upon the availability of a responsible and trusted family doctor. Unfortunately, head and neck patients often present special home care problems and temporary admission to an acute hospital ward may at times be necessary to cover periods of surgical or medical treatment, but this is usually the least desirable environment.
Recent estimates show that about two-thirds of all terminal cancer patients can be nursed at home, with one-third in hospital or hospice. If home care cannot be provided, then admission to a suitable hospice or hospital near home, within reach of the family doctor and where he can regularly attend, will usually be acceptable and may be preferred by some patients. A continuing care ward in cancer centres can also provide most valuable and expert hospice facilities, and at the Royal Marsden Hospital a home care Sister who works between the Continuing Care Unit and the home does provide essential support.
The question of who determines and undertakes palliative care is never easy. Most importantly, the principal nurse and the responsible doctor must be individuals in whom the patient and family have trust and confidence and who should be experienced in this field of therapy. It has been said that the doctor who first undertakes to treat any patient with cancer must be prepared to give continued care whatever the outcome. This is an ideal aim and, although seldom practicable, it stresses the need for continuity and for an experienced family doctor to accept such responsibility throughout a terminal illness.
Talk, tact and truth There remain the basic aspects of personal contact between the doctor, the patient and his relatives. A proper regard for communication is the hallmark of a good doctor, but in any situation relating to terminal illness it is absolutely vital. To quote the late Richard Asher10: 'A doctor must strive to give a good impression at all times, and by showing tolerance, lucidity and tact, gain the confidence and trust of those who depend upon him'. He must never give the impression of avoiding the patient or his relatives and should arrange regular, though not necessarily frequent interviews. Confidence and trust between patient and doctor constitute a personal and indefinable bond, but conscious efforts may well be required and will often then be successful.
The difficult decision of 'telling the truth to the patient' is really a matter of honesty and tact added to a personal understanding of the needs of each individual. There is no place for any general dogma unless it be a resolve not to tell an untruth. If a patient genuinely wishes to be told whether he has cancer or if he cannot be cured, then he must be told as gently as possible and with as much sugar on the pill as can be offered. Frequently this will be a relief and he will be genuinely grateful. Sometimes, however, the patient will be looking for reassurance rather than confirmation ofhis fears and care will be needed in giving an answer. Other patients do not wish to be told the facts and usually will not ask direct questions, having made their own assessment.
Finally, complete candour with close relatives is essential. They must know the full facts relating to the illness and understand the why and wherefore of treatment. The importance of good liaison between the doctor in charge and the relatives both before and after bereavement cannot be exaggerated in order to avoid subsequent misunderstandings, a sense of grievance, feelings of guilt or unjustified remorse. Some distress will be natural and unavoidable, but it should not arise from errors ofmanagement.
